Maynard Um
-
-
-
-
-
-
-
Xencor (XNCR) Tops Q3 EPS by 61c
-
-
-
-
-
-
-
Xencor, Inc. (XNCR) PT Lowered to $15 at RBC Capital, 'We Think XNCR Pipeline Is Undervalued'
-
-
-
-
-
-
-
Xencor (XNCR) appoints Todd Simpson to Board
-
-
-
-
-
-
-
Xencor, Inc. (XNCR) PT Raised to $34 at RBC Capital
-
-
-
-
-
-
-
Xencor (XNCR) Announces XmAb Drug Candidates in Autoimmune Disease with Near-Term Clinical Plans and Shares Clinical Progress in Early-Stage Oncology Programs
-
-
-
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

